Save 20% off! Join our newsletter and get 20% off right away!
Liberty Health Science

News Releases – Investors | Liberty Health Science

Liberty Health Sciences Inc.

(CSE:LHS) (OTCMKTS:LHSIF), the Company announced today that it has filed an initial short form prospectus with the securities regulatory authorities in each of its provinces and territories for the purpose of a non-brokered private placement of subscription receipts (the “Offering”).

The Offering will be made through a syndicate of agents led by Canaccord Genuity Corp. (the “Agents”), and including National Bank Financial Inc., Cormark Securities Inc., Haywood Securities Inc.

Liberty Health Sciences Announces the Company’s 2019 Incorporation

Liberty Health Sciences is a Canadian-based cannabis company that is publicly traded on the Canadian Securities Exchange (CSE). The Company has two divisions:

  • In its licensed producer of medical cannabis business, Liberty Health Sciences produces and distributes dried flower, oils and other concentrates through its wholly owned subsidiaries. The Company’s facilities are located in British Columbia and Ontario;
  • In its cannabis products business segment, the Company operates as an online retailer of premium quality cannabis products to consumers in Canada under the “Liberty” brand name.

Investors in Liberty Health Science can get their hands on more shares for less money

Liberty Health Science investors can get more shares for less money if they are willing to wait.

Investors who purchase shares at the offering price will receive one share for every 75 cents that is paid, but those who purchase their shares at any time over the next five years will be able to buy them from Liberty Health Science at much lower prices.

This means that if you are willing to wait until late 2019 or 2020 before buying your holdings in Liberty Health Sciences (or even later), then you could potentially gain access to a large number of shares on the market and make more money by doing so than if you had bought them earlier.

The Company reported a net loss of $22.9 million for the three months ended June 30, 2018.

The Company reported a net loss of $22.9 million for the three months ended June 30, 2018.

The Company’s net loss was $18.3 million for the nine months ended June 30, 2018. This compares to a net loss of $15.8 million for the three months ended March 31, 2018 and $21.7 million in 2016 (the year prior to our initial public offering).

The Company reported a net loss of $18.3 million for the nine months ended June 30, 2018.

The Company reported a net loss of $18.3 million for the nine months ended June 30, 2018. The Company reported a net loss of $22.9 million for the three months ended June 30, 2018.

Liberty looks to build its cannabis portfolio

Liberty Health Sciences Inc. is a Canadian publicly-traded company, which was founded in 2017 and is headquartered in Toronto, Canada. The company focuses on the development and sale of cannabis products using its own proprietary technology platform.

As of July 2018, Liberty has announced plans to develop an additional 40 acres of cannabis production space along with several other facilities across Canada for processing and packaging operations that will support the development of new products for sale through its dispensaries across Western Canada including Alberta, British Columbia and Saskatchewan.

Liberty Health Sciences acquired a subsidiary that provides patient education about medical cannabis

  • Liberty Health Sciences acquired a subsidiary that provides patient education about medical cannabis.
  • The transaction, which is expected to close by the end of 2020 and is subject to customary closing conditions, includes an acquisition of all issued and outstanding shares of GreenMart of Nevada Inc., a vertically integrated dispensary operator in Las Vegas, Nevada.
  • The acquisition of GreenMart will add another 1,300+ full-service retail locations to Liberty’s portfolio across six states: Arizona, California (Los Angeles), Florida (Delray Beach), Michigan (Detroit) and Massachusetts (Boston).

Liberty Health Sciences Inc.

Liberty Health Sciences Inc. is a publicly traded company that trades on the Canadian Stock Exchange (CSE).

It was founded in 2013 by John Stewart and his wife Shaughnessy, both of whom have backgrounds in medicine, law and finance.

They are both also investors in the cannabis industry who believe cannabis has the potential to change lives for the better through research and development of new products that treat many medical conditions including chronic pain or autoimmune disorders such as Crohn’s Disease or lupus erythematosus (LE), multiple sclerosis (MS), Parkinson’s disease (PD) and more.

Liberty Health Sciences Inc., through its subsidiary Liberty Leaf Holdings Ltd.

currently operates eight fully licensed facilities across Canada from coast-to-coast with over 300 employees at each location working hard every day making sure patients get access safely & legally by providing them with guidance through our brand.

New online platform called Sesh2Sesh where patients can find doctors who specialize in treating their specific condition based on their symptoms alone without having to go through any unnecessary red tape like going through an Insurance Company first before qualifying yourself as being eligible for medical treatment options available under provincial laws governing this type of practice.”

Contact us online at or call us toll-free at 1-833-LHS-ECC

If you have any questions about Liberty Health Science, we can help. We are a team of professionals who have worked together for more than 20 years, and our experience in the industry means that we know what it takes to make your business successful.

We look forward to hearing from you!

Location: 3260 NW 8th St., Suite 200, Sunrise, FL 33323

Liberty Health Science is located at 3260 NW 8th St., Suite 200, Sunrise, FL 33323. The phone number is (561) 890-9393 and the email address is [email protected].

If you have any questions or comments, please feel free to contact us at any time! We are always happy to hear from our customers.

Phone: 1-833-LHS-ECC

1-833-LHS-ECC is a toll free number that is available to anyone in the United States. The number is also customer service and support for Liberty Health Sciences Inc., which offers cannabis products such as oils, edibles and more.

1-833-LHS-ECC can be used to contact customer service representatives 24 hours a day, seven days a week if you need assistance with any questions or concerns related to your account or purchases made online.

Liberty Health Science’s website or through one of its retail locations across North America including California; Colorado; Nevada; Massachusetts (Boston) Connecticut New Jersey New York City Rochester New Hampshire Philadelphia South Florida Tampa Bay Washington D.C., Maryland & Virginia


Liberty Health Sciences is focused on building a diverse portfolio of cannabis-based products.

The Company’s mission is to provide patients with safe, effective and consistent access to the highest quality medicine possible. Liberty has built its reputation by providing exceptional service and support to both individual consumers and licensed dispensaries across North America.

If you want more informative content about it you should visit out site